Cargando…
Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis
BACKGROUND: Fibrotic hypersensitivity pneumonitis (HP) is a chronic interstitial lung disease caused by allergic responses to repeated exposures to a causative antigen. Therapeutic evidence of the use of corticosteroids to treat fibrotic HP remains lacking, although corticosteroids are recognized as...
Autores principales: | Ejima, Masaru, Okamoto, Tsukasa, Suzuki, Takafumi, Anzai, Tatsuhiko, Takahashi, Kunihiko, Miyazaki, Yasunari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290597/ https://www.ncbi.nlm.nih.gov/pubmed/34281549 http://dx.doi.org/10.1186/s12890-021-01608-1 |
Ejemplares similares
-
Clusters of comorbidities in fibrotic hypersensitivity pneumonitis
por: Prior, Thomas Skovhus, et al.
Publicado: (2022) -
Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
por: Chen, Xueying, et al.
Publicado: (2023) -
Fibrosis score predicts mortality in patients with fibrotic hypersensitivity pneumonitis
por: Oh, Ju Hyun, et al.
Publicado: (2023) -
Disruption in the balance between apolipoprotein A‐I and mast cell chymase in chronic hypersensitivity pneumonitis
por: Inoue, Yukihisa, et al.
Publicado: (2020) -
Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management
por: Kouranos, Vasileios, et al.
Publicado: (2017)